Universal Cells
Sayaka O. is a skilled professional with a background in bioengineering and biological sciences. With experience in various research roles at companies like Universal Cells and Prevail Therapeutics, as well as academic institutions like the University of Pennsylvania School of Medicine, Sayaka has built a strong foundation in clinical gene editing, preclinical research, and managing laboratory facilities. With a Master of Science in Engineering in Bioengineering from the University of Pennsylvania and a Bachelor of Science in Biological Sciences from Drexel University, Sayaka brings a wealth of knowledge and expertise to their work in the field.
This person is not in any offices
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.